These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19665473)

  • 1. Animal models of human anthrax: the Quest for the Holy Grail.
    Goossens PL
    Mol Aspects Med; 2009 Dec; 30(6):467-80. PubMed ID: 19665473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of toxins to the pathogenesis of inhalational anthrax.
    Tournier JN; Quesnel-Hellmann A; Cleret A; Vidal DR
    Cell Microbiol; 2007 Mar; 9(3):555-65. PubMed ID: 17223930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of inhalational anthrax animal models.
    Twenhafel NA
    Vet Pathol; 2010 Sep; 47(5):819-30. PubMed ID: 20656900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key aspects of the molecular and cellular basis of inhalational anthrax.
    Cote CK; Welkos SL; Bozue J
    Microbes Infect; 2011 Dec; 13(14-15):1146-55. PubMed ID: 21816231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.
    Grinberg LM; Abramova FA; Yampolskaya OV; Walker DH; Smith JH
    Mod Pathol; 2001 May; 14(5):482-95. PubMed ID: 11353060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
    Puhar A; Montecucco C
    Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
    Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL
    PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.
    Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM
    Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacillus anthracis: interactions with the host and establishment of inhalational anthrax.
    Passalacqua KD; Bergman NH
    Future Microbiol; 2006 Dec; 1(4):397-415. PubMed ID: 17661631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of inhalational anthrax infection in the african green monkey.
    Twenhafel NA; Leffel E; Pitt ML
    Vet Pathol; 2007 Sep; 44(5):716-21. PubMed ID: 17846250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the incubation period of inhalational anthrax.
    Wilkening DA
    Med Decis Making; 2008; 28(4):593-605. PubMed ID: 18556642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhalation anthrax].
    Hansen TH
    Ugeskr Laeger; 2000 Sep; 162(36):4786-9. PubMed ID: 10994373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.
    Meyerhoff A; Albrecht R; Meyer JM; Dionne P; Higgins K; Murphy D
    Clin Infect Dis; 2004 Aug; 39(3):303-8. PubMed ID: 15306995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.
    Lawrence WS; Hardcastle JM; Brining DL; Weaver LE; Ponce C; Whorton EB; Peterson JW
    Comp Med; 2009 Jun; 59(3):257-65. PubMed ID: 19619416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.
    Gutting BW; Marchette D; Sherwood R; Andrews GA; Director-Myska A; Channel SR; Wolfe D; Berger AE; Mackie RS; Watson BJ; Rukhin A
    J Theor Biol; 2013 Jul; 329():20-31. PubMed ID: 23567649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anthrax].
    Bol P
    Ned Tijdschr Tandheelkd; 2003 May; 110(5):198-9. PubMed ID: 12784517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.